Alpha Biopharma (jiangsu) Co., Ltd.

This early-stage trial tests whether adding zorifertinib to the standard drug osimertinib is safe and helpful for people with advanced lung cancer that has spread to the membranes around the brain. About 42 participants will receive the combination pills daily. The main goal is t…

This study is testing a drug called zorifertinib as the first treatment for people with advanced non-small cell lung cancer that has a specific gene mutation (EGFR) and has spread to the brain or spinal cord. The trial will enroll 800 participants and compare zorifertinib to othe…